Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma

British Journal of Cancer

Volumn 77, Issue 6, 1998, Pages 880-883

  Hii, S I ^a   Nicol, D L ^a   Gotley, D C ^a   Thompson, L C ^a   Green, M K ^a   Jonsson, J R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Angiotensin; Captopril; Renal cell carcinoma; SCID; Tumour

Indexed keywords

ANGIOTENSIN; CAPTOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KIDNEY MASS; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; XENOGRAFT;

EID: 0031937612     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.145     Document Type: Article

References (25)

1. Antonaccio MJ, Rubin B, Horowitz ZP, Laffan RJ, Goldberg ME, High JP, Harris DN and Zaidi I (1979) Effects of chronic treatment with captopril (SQ14,225). an orally active inhibitor of angiotensin 1-converting enzyme in spontaneously hypertensive rats. Jpn J Pharmacol 29: 285-294
2. Burris JF (1995) The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension. J Clin Pharmacol 35: 337-342
3. Chobanian MC and Julin CM (1991) Angiotensin II stimulates ammoniagenesis in canine renal proximal tubule segments. Am J Physiol 260: F19-F26
4. Cogan MG (1990) Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 15: 451-458
5. Douglas JG (1987) Angiotensin receptor subtypes of the kidney cortex. Am J Physiol 253: F1-F7
6. Fernandez LA, Twickler J and Mead A (1985) Neovascularisation produced by angiotensin II. J Lab Clin Med 105: 141-145
7. Folkman J and Klagsburn M (1987) Angiogenic factors. Science 235: 442-447
8. Giudicelli JF, Richer C, Freslon JL, Glasson S and Decourt S (1981) Comparison of the effects of beta-blockers and captopril on the development of genetic hypertension in the rat. Arch Mal Coeur Vaiss 74: 51-59
9. Goldfarb DA, Diz DI, Tubbs RR, Ferrario CM and Novick AC (1994) Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma. J Urol 151: 208-213
10. Goligorsky MS, Osborne D, Howard T, Hruska KA and Karl IE (1987) Hormonal regulation of gluconeogenesis in cultured proximal tubular cells: Role of cytosolic calcium. Am J Physiol 253: F802-809
11. Harris PJ (1992) Regulation of proximal tubule function by angiotensin. Clin Exp Pharmacol Physiol 19: 213-222
12. Hernandez I, Cowley AW Jr, Lombard JH and Greene AS (1992) Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats. Am J Physiol 263: H8664-H8667
13. Johnston CI, Fabris B and Jandeleit K (1993) Intrarenal renin-angiotensin system in renal physiology and pathophysiology. Kidney Int Suppl 42: S59-S63
14. 1-blockade on the development of hypertension in the spontaneously hypertensive rat. Eur J Pharmacol 211: 263-268
15. Le Noble FAC, Hekking JW, Van Straaten HWM, Slaaf DW and Struijker-Boudier HA (1991) Angiotensin II stimulates angiogenesis in the chorio-allantioc membrane of the chick embryo. Eur J Pharmacol 195: 305-306
16. Le Noble FAC, Schreurs NH, Van Straaten HW, Slaaf DW, Smits JFM, Rogg H and Struijker-Boudier HAJ (1993) Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am J Physiol 264: R460-R465
17. Mancilla-Jimenez R, Stanley RJ and Blath RA (1976) Papillary renal cell carcinoma: a clinical, radiological and pathologic study of 34 cases. Cancer 38: 2469-2480
18. Norman J, Badie-Dezfooly B, Nord EP, Kurtz I, Schlosser J, Chaudhari A and Fine LG (1987) EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol 253: F299-F309
19. Pfeffer MA, Braunwald E, Move LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH and Hawkins CM on behalf of the SAVE Investigators (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327: 669-677
20. Reddy MK, Baskaran K and Molteni A (1995) Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc Soc Exp Biol Med 210: 221-226
21. Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Polverini PJ and Bouck NP (1996) Captopril inhibits angiogensis and slows the growth of experimental tumours in rats. J Clin Invest 98: 671-679
22. Wolf G (1993) Regulating factors of renal tubular hypertrophy. Clin Invest 71: 867-870
23. Wolf G and Neilson EG (1990) Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 259: F768-F777
24. 1 receptor. Nephrol Dial Transplant 8: 128-133
25. Wolf G, Ziyadeh FN, Zahner G and Stahl RAK (1995) Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: attenuation after stable transfection with the c-mas oncogene. Kidney Int 48: 1818-1827